Previously, Diep QN et al. and Ryan MJ et al. had reported an attenuation of AngII-induced hypertensive effect in response to RGZ or pioglitazone and in a transgenic model of hypertension with RGZ treatment, respectively [8, 23]. The gene discussed is AGT; the disease is hypertensive disorder.